Establishment of imaging diagnostic models for novel coronavirus pneumonia (COVID-19) and related brain injury based on artificial intelligence

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2000036849

Enrollment

Unknown

Registered

2020-08-25

Start date

2020-10-01

Completion date

Unknown

Last updated

2020-11-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Novel Coronavirus Pneumonia (COVID-19)

Interventions

Gold Standard:Real-time fluorescence reverse transcription polymerase chain reaction

Index test:IVIM-DWI,3D-ASL,fMRI,DTI,PWI

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Patients with COVID-19, fungal pneumonia or other types of pneumonia confirmed by nucleic acid or pathological test; 2. Patients with chest CT examination.

Exclusion criteria

Exclusion criteria: 1. All patients with pneumonia without nucleic acid or pathological/clinical confirmation; 2. Patients lack chest CT imaging data.

Design outcomes

Primary

Measure	Time frame
Sensitivity;Specificity;	—

Countries

China

Contacts

Public ContactBo Yin

Department of Radiology, Huashan Hospital, Fudan University

yinbo7@163.com+86 13916420317

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026